Kymera Therapeutics, Inc. (KYMR)
Biological Products, (No Diagnostic Substances)
Latest Price
$113.15
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
15.42
P/B Ratio
7.34
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 12.35M | $1.42B | 14.92% | +649.3K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 8.66M | $992.0M | 10.46% | -- | 2026-06-30 |
| Avoro Capital Advisors LLC | 7.47M | $857.0M | 9.03% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.11M | $815.0M | 8.59% | +1.05M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 6.26M | $717.0M | 7.56% | +792.3K | 2026-06-30 |
| BlackRock, Inc. | 5.54M | $635.0M | 6.69% | +477.3K | 2026-06-30 |
| BVF INC/IL | 3.87M | $444.0M | 4.68% | -1.63M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.68M | $421.0M | 4.44% | -214.7K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.99M | $343.0M | 3.61% | +118.1K | 2026-06-30 |
| Siren, L.L.C. | 2.94M | $336.0M | 3.55% | -251.0K | 2026-06-30 |